Concordance Clusters
Term Clusters
Concordance terms grouped by clinical domain. Terms may appear in multiple clusters if they span topics.
← Full Index 82 clusters · 6909 total terms
anesthetic 9 terms
Anesthesia Induction (especially Hemodynamic Instability) Dissociative Anesthetic ICU Sedation For Mechanically Ventilated Patients Induction And Maintenance Of General Anesthesia Intravenous General Anesthetic Off-label: Chronic Pain, Opioid-sparing Analgesia Procedural Analgesia/sedation Procedural Sedation Treatment-resistant Depression (esketamine/Spravato)
antiarrhythmic 31 terms
Antiarrhythmic (Class IA) Antiarrhythmic (Class IB) Antiarrhythmic (Class IB) / Local Anesthetic Antiarrhythmic (Class IC) Antiarrhythmic (Class III) Antiarrhythmic (Class III/II) Antiarrhythmic (Class V) Atrial Fibrillation (maintenance Of Sinus Rhythm) Atrial Fibrillation/flutter Cinchonism Diagnosis Of Wide-complex Tachycardias HCN Channel Blocker HFrEF With HR ≥70 Bpm In Sinus Rhythm (SHIFT Trial) Local/regional Anesthesia Myotonic Dystrophy (off-label) Neuropathic Pain (off-label) Paroxysmal AF/SVT (in Structurally Normal Hearts) Paroxysmal AF/SVT In Structurally Normal Hearts Paroxysmal Supraventricular Tachycardia Paroxysmal Ventricular Arrhythmias Prevention Of Recurrent VT/VF PSVT Termination (drug Of Choice) QT Prolongation Stable Angina (Europe) Torsades De Pointes Ventricular Arrhythmias Ventricular Arrhythmias (sustained) Ventricular Arrhythmias (VT/VF — Second-line To Amiodarone In ACLS) Ventricular Arrhythmias (VT/VF) Ventricular Arrhythmias In Setting Of Acute MI Ventricular Fibrillation/VT (ACLS)
antibiotic 282 terms
Acne Vulgaris Acne Vulgaris (oral) Acne Vulgaris (topical) Active Tuberculosis (intensive And Continuation Phases) Active Tuberculosis (part Of Standard 4-drug Initial Regimen: RIPE) Active Tuberculosis (part Of Standard RIPE Regimen For First 2 Months — Sterilizing Phase) Acute Bacterial Sinusitis Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Due To Gram-positive Organisms Including MRSA Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Including MRSA Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Including MRSA — Single 1200 Mg Dose Acute Exacerbation Of Chronic Bronchitis Acute Exacerbations Of Chronic Bronchitis Acute Pelvic Infections Alternative For Osteomyelitis In Select Patients (off-label) Amebiasis (intestinal And Amebic Liver Abscess) Aminoglycoside Antibiotic Aminomethylcycline Tetracycline Amoebic Liver Abscess Amphenicol Antibiotic Anaerobic Infections Anaerobic Wound Infections Anthrax Anthrax (alternative To Ciprofloxacin) Anthrax (drug Of Choice) Anthrax Prophylaxis And Treatment Antibiotic Antibiotic (beta-lactam/beta-lactamase Inhibitor Combination) Antibiotic (GI-specific) Antibiotic (penicillin) Antibiotic / Antiprotozoal Antimycobacterial Agent Aspiration Pneumonia Atypical Pneumonia (Mycoplasma, Chlamydophila) Bacterial Meningitis Bacterial Meningitis (Listeria, Group B Streptococcus) Bacterial Meningitis (pediatric/adult) Bacterial Meningitis (penicillin-allergic Patients) Bacterial Vaginosis Beta-lactam-allergic Patient With Serious Gram-positive Infections Beta-lactam/beta-lactamase Inhibitor Combination Bite Wounds (animal/human) Bone And Joint Infections Bone/joint Infections (Pseudomonas) Bone/joint Infections (step-down Therapy) Brucellosis Carbapenem Antibiotic Carbapenem-spectrum Infections: ESBL-producing Enterobacteriaceae Chlamydia (1 G Single Dose) Chlamydia (drug Of Choice) Chlamydial Infections Chlamydial Infections In Pregnancy Cholera Clostridioides Difficile Colitis (oral — Not Absorbed) Clostridioides Difficile Colitis (vancomycin Or Fidaxomicin Preferred For Severe Cases) Clostridioides Difficile Infection (CDI) — Preferred Over Vancomycin For Recurrent CDI Due To Lower Recurrence Rates Combination Therapy For MDR Acinetobacter Baumannii Community-acquired Bacterial Pneumonia (CABP) Community-acquired MRSA Decolonization Community-acquired Pneumonia Community-acquired Pneumonia (atypical Organisms) Community-acquired Pneumonia (atypical Pathogens) Community-acquired Pneumonia (atypical) Community-acquired Pneumonia (hospitalized Patients) Community-acquired Pneumonia (including Atypical Pathogens) Community-acquired Pneumonia (mild-moderate) Community-acquired Pneumonia (outpatient) Complicated Intra-abdominal Infection (cIAI) Complicated Intra-abdominal Infection (with Metronidazole) Complicated Intra-abdominal Infections Complicated Intra-abdominal Infections (cIAI) Complicated Skin And Skin Structure Infections (cSSSI) Due To Gram-positive Organisms Including MRSA Complicated Skin And Soft Tissue Infections Complicated Skin/soft Tissue Infections Complicated Skin/soft Tissue Infections (cSSSI) Complicated Skin/soft Tissue Infections Due To Gram-positive Organisms Complicated Urinary Tract Infections Complicated Urinary Tract Infections (cUTI) And Acute Pyelonephritis Due To Enterobacteriaceae Including CRE Complicated UTI Complicated UTI (cUTI) Complicated UTI (Pseudomonas) Complicated UTI And Pyelonephritis Complicated UTI Due To MDR Pseudomonas Complicated UTI Including Pyelonephritis Congenital Toxoplasmosis Cystic Fibrosis — Inhaled Tobramycin For Chronic Pseudomonas Suppression Dermatitis Herpetiformis Diabetic Foot Infections (mild-moderate) Diarylquinoline Antimycobacterial Diphtheria And Legionellosis Empiric Therapy For Severe Gram-negative Infections Empiric Therapy In High-risk Hospital Patients Endocarditis (non-MRSA) Endocarditis Prophylaxis Enterococcal Endocarditis (in Combination With Penicillin) Enterococcal Infections (often Combined With Gentamicin) Extensively Drug-resistant Tuberculosis (XDR-TB) Or Treatment-intolerant/non-responsive MDR-TB — As Part Of The BPaL Regimen (Bedaquiline + Pretomanid + Linezolid) Febrile Neutropenia Febrile Neutropenia (empiric) Febrile Neutropenia (in Combination With Aminoglycoside Or Fluoroquinolone) Febrile Neutropenia (with Beta-lactam) Fifth-generation Cephalosporin First-generation Cephalosporin Fluorocycline Antibiotic Fluoroquinolone Antibiotic Gastroparesis (prokinetic, Off-label, Low Doses) Gentamicin-susceptible Pseudomonas Infections Giardiasis Glycylcycline Antibiotic Gonorrhea Gonorrhea (drug Of Choice — IM) Gonorrhea (no Longer First-line Due To Resistance) Gonorrhea (penicillin-allergic) Gonorrhea (with Ceftriaxone — No Longer Routinely Added) Gram-negative Septicemia Group A Streptococcal Infections Group A Streptococcal Pharyngitis Gynecological Infections H. Pylori Eradication (alternative) H. Pylori Eradication (component Of Triple Therapy) H. Pylori Eradication (component) H. Pylori Eradication (quadruple Therapy) Helicobacter Pylori Eradication (triple Or Quadruple Therapy) Hepatic Encephalopathy Prevention (secondary) Hospital-acquired And Ventilator-associated Pneumonia Due To Susceptible S. Aureus Hospital-acquired Pneumonia Hospital-acquired Pneumonia (off-label In Some Regions) Hospital-acquired Pneumonia / Ventilator-associated Pneumonia Hospital-acquired Pneumonia And VAP (gram-negative) Hospital-acquired Pneumonia/VAP Due To Carbapenem-resistant Organisms Hospital-acquired/VAP Due To MDR Pseudomonas IBS-diarrhea Predominant (IBS-D) Infective Endocarditis (streptococcal) Intra-abdominal Infections Intra-abdominal Infections (with Anaerobic Coverage) Intra-abdominal Infections (with Cephalosporin For Aerobic Coverage) Intra-abdominal Infections (with Metronidazole) Intrapartum GBS Prophylaxis KPC-producing Enterobacteriaceae Infections Latent TB Infection (LTBI) — 3HP Regimen: Weekly Rifapentine + Isoniazid For 12 Weeks Latent TB Infection (LTBI) — 9 Months Or 3 Months With Rifapentine/rifampin Short-course Legionella (combination Therapy) Leprosy (Hansen's Disease — Part Of Multidrug Therapy) Leprosy (part Of Multidrug Therapy — WHO Regimen) Lipoglycopeptide Antibiotic Lower Respiratory Tract Infections Lower Respiratory Tract Infections (gram-negative) LTBI (3-4 Months With Isoniazid Or 4 Months Alone) Lyme Disease (alternative To Doxycycline) Lyme Disease (disseminated/severe) Lyme Disease (early Localized — Drug Of Choice) Lyme Disease (early Localized) Lyme Disease (early) M. Abscessus Infections MAC Infections (in Combination) MAC Prophylaxis And Treatment (in HIV) MAC Prophylaxis/treatment (HIV) MAC Treatment (in Combination) Macrocyclic Antibiotic Macrolide Antibiotic Malaria Prophylaxis MDR Acinetobacter Infections (high-dose Sulbactam) MDR-TB (second-line) Meningitis (gram-negative) Meningococcal Carrier State Meningococcal Meningitis Meningococcal Prophylaxis (close Contacts) Methicillin-susceptible Staphylococcus Aureus (MSSA) Infections (bacteremia, Endocarditis, Osteomyelitis, Skin/soft Tissue) Mild Community-acquired Pneumonia (streptococcal) Mild Skin And Soft Tissue Infections Monobactam Antibiotic MRSA Infections (bacteremia, Pneumonia, Endocarditis, Osteomyelitis — IV) MRSA Infections (including Pneumonia) MRSA Skin And Soft Tissue Infections (mild-moderate) MRSA Skin/soft Tissue Infections (mild-moderate) MSSA Infections (bacteremia, Endocarditis, Osteomyelitis, Skin/soft Tissue) Multidrug-resistant Tuberculosis (MDR-TB) As Part Of Combination Therapy Multidrug-resistant Tuberculosis (MDR-TB) As Part Of Combination Therapy (when Other Regimens Cannot Be Constructed) Mycobacterium Avium Complex (MAC) — Treatment In Non-HIV Patients Mycobacterium Avium Complex (MAC) Prophylaxis In HIV (CD4 <50) Neonatal Infections Neurosyphilis (aqueous Penicillin G IV) Nicotinamide Analog Antimycobacterial Nitrofuran Antibiotic Nitroimidazole Antibiotic/antiprotozoal Nitroimidazole Antimycobacterial Nocardia Infections Nocardiosis (alternative) Nosocomial Pneumonia Due To S. Aureus (MRSA/MSSA) NTM Infections (Mycobacterium Abscessus) Ophthalmic Use (topical) Osteomyelitis (oral Step-down) Otitis Media Otitis Media (first-line) Otitis Media (treatment Failure) Oxazolidinone Antibiotic PCP Treatment (in Combination With Trimethoprim) Pediatric Otitis Media (5-day Pack) Pelvic Inflammatory Disease Penicillin-allergic Patients Needing Gram-negative Coverage Penicillinase-resistant Penicillin Pertussis (whooping Cough) Pharyngitis (streptococcal, Group A) Pharyngitis/tonsillitis Pharyngitis/tonsillitis (penicillin-allergic) Plague (Yersinia Pestis) Plague And Tularemia (second-line) Pneumococcal Pneumonia (susceptible Strains) Pneumocystis Jirovecii Pneumonia (PCP) Prophylaxis In HIV Pneumocystis Jirovecii Pneumonia (PCP) Treatment And Prophylaxis Preferred Over Vancomycin For Serious MSSA Infections Prophylaxis For Rheumatic Fever Recurrence Prophylaxis In High-risk Cardiac Procedures (with Ampicillin) Prostatitis Pseudomonas Aeruginosa Infections Pseudomonas Aeruginosa Infections (susceptible) Pseudomonas Aeruginosa Infections (systemic) Pyelonephritis Rheumatoid Arthritis (adjunct) Rickettsial Diseases (Rocky Mountain Spotted Fever — Drug Of Choice) Rifamycin Antibiotic Riminophenazine Antibiotic Rocky Mountain Spotted Fever (alternative When Doxycycline Contraindicated) Rocky Mountain Spotted Fever (Rickettsia) Rosacea Second-generation Cephalosporin Second-generation Cephalosporin (cephamycin) Sepsis (empiric Broad-spectrum Therapy) Sepsis (empiric) Septicemia Serious Gram-negative Infections (bacteremia, Pneumonia, UTI) Serious Gram-negative Infections Resistant To Gentamicin And Tobramycin Severe Skin/soft Tissue Infections (MRSA) Sinusitis Sinusitis (moderate-severe) Skin And Soft Tissue Infections Skin And Soft Tissue Infections (MSSA) Skin And Soft Tissue Infections Due To MSSA Skin/soft Tissue Infections Skin/soft Tissue Infections (gram-negative) Spontaneous Bacterial Peritonitis Prophylaxis/treatment Staphylococcal Bacteremia (mild) Staphylococcal Prosthetic Joint/device Infection (adjunctive — Not Monotherapy) Streptococcal Pharyngitis Streptococcal Pharyngitis (penicillin Alternative) Sulfonamide Antibiotic Sulfone Antibiotic Surgical Prophylaxis Surgical Prophylaxis (alternative) Surgical Prophylaxis (colorectal) Synergistic Therapy For Gram-positive Endocarditis (with Penicillin Or Ampicillin) Syphilis (drug Of Choice — Benzathine Penicillin G IM) Tetracycline Antibiotic Third-generation Cephalosporin Toxoplasmosis (in Combination With Pyrimethamine And Leucovorin — Treatment And Prophylaxis In HIV) Traveler's Diarrhea Traveler's Diarrhea (non-invasive E. Coli) Trichomoniasis Trichomoniasis (drug Of Choice) Tuberculosis (always Combined — Never Monotherapy To Prevent Resistance) Tuberculosis (as Part Of Combination Therapy — Second-line) Tuberculosis (rifampin-intolerant Or Drug Interactions) Tuberculosis (second-line) Tuberculosis Treatment (first-line; Always Combined With Other Agents) Tularemia Typhoid Fever Typhoid Fever (Salmonella Typhi) Uncomplicated Gonorrhea Uncomplicated Skin And Soft Tissue Infections (MSSA) Uncomplicated Urinary Tract Infections (UTI) Uncomplicated UTI Uncomplicated UTI (susceptible E. Coli) Urinary Tract Infections Urinary Tract Infections (ampicillin-sensitive Organisms) Urinary Tract Infections (complicated) Urinary Tract Infections (gram-negative) Urinary Tract Infections (serious) UTI UTI (E. Coli, Community-acquired — First-line If Local Resistance <20%) UTI (susceptible Organisms) UTI Prophylaxis (chronic Suppression) VRE Infections
anticoagulant 27 terms
ACS ACS (NSTEMI) ACS (NSTEMI/STEMI) AF Stroke Prevention AF Stroke Prevention (non-valvular) Anticoagulant Atrial Fibrillation Stroke Prevention Bridging Bridging To Warfarin Direct Oral Anticoagulant (DOAC) DVT/PE Treatment DVT/PE Treatment (especially Cancer-associated) DVT/PE Treatment And Prevention Hemodialysis HIT Management (alternative) HIT Type II Management HIT With Thrombosis Requiring Anticoagulation Mechanical Heart Valve Nonvalvular Atrial Fibrillation (stroke Prevention) PCI In ACS PCI In HIT Patients Post-arthroplasty Thromboprophylaxis Post-MI LV Thrombus Secondary ACS/CAD Prevention (2.5 Mg BID With Aspirin) Surgical Thromboprophylaxis Thromboprophylaxis Treatment Of DVT And Pulmonary Embolism Following 5-10 Days Of Initial Parenteral Anticoagulation
antidementia 14 terms
Alzheimer's Disease (mild, Moderate, Severe) Alzheimer's Disease Dementia (mild To Severe) Cholinesterase Inhibitor Cholinesterase Inhibitor / Nicotinic Receptor Modulator Dementia Associated With Parkinson's Disease (off-label) Mild To Moderate Alzheimer's Disease Dementia Moderate To Severe Alzheimer's Disease (monotherapy Or Combination With Cholinesterase Inhibitor) Myasthenia Gravis (symptomatic Treatment) NMDA Receptor Antagonist Parkinson's Disease Dementia (first FDA-approved Treatment For This Indication) Postoperative Ileus Reversal Of Non-depolarizing NMBA (moderate Depth) Urinary Retention Vascular Dementia (off-label)
antidepressant 61 terms
ADHD (off-label) Antidepressant Antidepressant / Smoking Cessation Atypical Depression Bipolar I Depression (with Olanzapine) Bulimia Nervosa Chronic Musculoskeletal Pain Diabetic Peripheral Neuropathy Fibromyalgia Generalized Anxiety Disorder Major Depressive Disorder Major Depressive Disorder (particularly Atypical Features, Treatment-resistant) Major Depressive Disorder (particularly Treatment-resistant) Major Depressive Disorder (transdermal Patch Only) Migraine Prophylaxis Monoamine Oxidase Inhibitor (MAOI) Multimodal Antidepressant Neuropathic Pain Nocturnal Enuresis In Children Noradrenergic And Specific Serotonergic Antidepressant (NaSSA) Obsessive-compulsive Disorder OCD OCD (FDA-approved) Off-label: ADHD Off-label: Anxiety Off-label: Cataplexy (narcolepsy) Off-label: Chronic Pain Off-label: COVID-19 (investigational) Off-label: Depression Off-label: Fibromyalgia Off-label: Fibromyalgia Pain Off-label: Fibromyalgia, Neuropathic Pain, Hot Flashes, Migraine Prevention Off-label: Generalized Anxiety Disorder Off-label: Insomnia Off-label: Insomnia (most Common Use At Low Doses) Off-label: Interstitial Cystitis Off-label: Major Depressive Disorder Off-label: Nausea Off-label: Neuropathic Pain Off-label: OCD Off-label: Panic Disorder Off-label: PTSD Off-label: Smoking Cessation Off-label: Vasomotor Symptoms Of Menopause Off-label: Weight Gain In Cancer/HIV Cachexia Panic Disorder Parkinson's Disease (oral; Separate Entry) Premenstrual Dysphoric Disorder Premenstrual Dysphoric Disorder (Sarafem) PTSD Seasonal Affective Disorder Serotonin Antagonist And Reuptake Inhibitor (SARI) Sexual Dysfunction From SSRIs (off-label) Smoking Cessation (Zyban) SNRI Social Anxiety Disorder Social Anxiety Disorder (CR Formulation) SPARI (serotonin Partial Agonist Reuptake Inhibitor) SSRI Stress Urinary Incontinence (international) Tricyclic Antidepressant (TCA)
antidiabetic 42 terms
Alpha-glucosidase Inhibitor Amylin Analog Antidiabetic Antidiabetic / Weight Management Cardiovascular Risk Reduction In T2DM With Established CVD Cardiovascular Risk Reduction In T2DM With Established CVD (Ozempic) Cardiovascular Risk Reduction In T2DM With Established CVD (Victoza) Cardiovascular Risk Reduction In T2DM With Established CVD Or CV Risk Factors Chronic Kidney Disease (CKD) — Reduces Progression Chronic Kidney Disease (CKD) With Albuminuria Chronic Weight Management (Wegovy) Chronic Weight Management In Obesity (Zepbound) CKD With Albuminuria (eGFR 25–75 ML/min) DPP-4 Inhibitor Dual GLP-1/GIP Receptor Agonist (twincretin) GLP-1 Receptor Agonist Heart Failure With Preserved Ejection Fraction (HFpEF) Heart Failure With Reduced Ejection Fraction (HFrEF) Heart Failure With Reduced Ejection Fraction (HFrEF) — Reduces HF Hospitalization And CV Death Meglitinide Non-alcoholic Steatohepatitis (emerging: NASH/MASH) Non-alcoholic Steatohepatitis (NASH) — Off-label Obesity Management — BMI ≥30 Or ≥27 With Comorbidity (Saxenda) Off-label: Heart Failure With Preserved Ejection Fraction (HFpEF) Polycystic Ovary Syndrome (off-label) Prevention Of Type 2 Diabetes In High-risk Patients (prediabetes) SGLT-2 Inhibitor Sulfonylurea Thiazolidinedione Type 1 Diabetes Mellitus (adjunct To Mealtime Insulin) Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus (adjunct To Mealtime Insulin) Type 2 Diabetes Mellitus (first-line) Type 2 Diabetes Mellitus (glycemic Control + CV Risk Reduction) Type 2 Diabetes Mellitus (glycemic Control) Type 2 Diabetes Mellitus (mealtime Insulin Secretagogue) Type 2 Diabetes Mellitus (mealtime) Type 2 Diabetes Mellitus (monotherapy Or Combination) Type 2 Diabetes Mellitus (Mounjaro) Type 2 Diabetes Mellitus (reduces Postprandial Hyperglycemia) Type 2 Diabetes Mellitus (restricted Use — Only For Patients Who Cannot Use Other Agents And Are Already On Rosiglitazone) Type 2 Diabetes Mellitus (Victoza)
antiemetic 37 terms
5-HT3 Receptor Antagonist Acute And Delayed CINV (highly Emetogenic Chemotherapy) Adjunct To Analgesia Agitation In Emergency Settings (off-label) Allergic Conditions Anorexia And Weight Loss In AIDS Patients Anticholinergic / Antiemetic Antiemetic Butyrophenone / Dopamine Antagonist Cannabinoid / Antiemetic Chemotherapy-induced Nausea And Vomiting (CINV) Chemotherapy-induced Nausea/vomiting (CINV) CINV Refractory To Conventional Antiemetics Gastroparesis (diabetic And Post-surgical) GERD (short-term) Hiccups Highly Emetogenic Chemotherapy CINV (prevention) Motion Sickness Motion Sickness (prevention) Nausea And Vomiting Nausea And Vomiting (adjunct) Nausea Associated With Surgery Nausea/vomiting Neurokinin-1 Receptor Antagonist Phenothiazine / Antihistamine PONV (prevention And Treatment) PONV (prevention) Post-operative Nausea/vomiting (PONV) Post-operative Nausea/vomiting (prevention) Postoperative Nausea And Vomiting (PONV) Pregnancy Nausea/vomiting (off-label But Common) Prevention Of Acute And Delayed CINV (combination Therapy) Prevention Of PONV Prokinetic / Antiemetic Radiation-induced Nausea Radiation-induced Nausea And Vomiting Sedation (preoperative)
antiepileptic 45 terms
Absence Epilepsy (ONLY — Drug Of First Choice For Pure Absence Seizures) Absence Seizures (drug Of Choice) Adjunctive Therapy For Partial (focal) Seizures In Adults Alcohol/benzodiazepine Withdrawal (off-label) Antiepileptic Antiepileptic / Analgesic Antiepileptic / Mood Stabilizer Antiepileptic Drug Antiepileptic Drug / Barbiturate Bipolar Depression Bipolar Disorder (maintenance) Bipolar Disorder (mania And Maintenance) Bipolar Disorder (manic Episodes) Bipolar Disorder (off-label) Cardiac Arrhythmias (IV) Diabetic Peripheral Neuropathy Epilepsy (focal And Generalized Seizures) Febrile Seizures (prophylaxis — Historical; Less Preferred Now) Fibromyalgia Focal And Generalized Tonic-clonic Seizures Focal Seizures Focal-onset Seizures Focal-onset Seizures (adjunct) Generalized Tonic-clonic Seizures Juvenile Myoclonic Epilepsy Lennox-Gastaut Syndrome Loading Dose Replacement For Oral Phenytoin When Oral Route Is Unavailable Migraine Prophylaxis Neonatal Seizures (drug Of Choice) Obesity (Qsymia — Combination With Phentermine) Off-label: Neuropathic Pain, Fibromyalgia, Anxiety Partial (focal) Seizures (adjunctive Or Monotherapy In Adults) Partial (focal) Seizures (monotherapy And Adjunctive Therapy) Partial And Generalized Seizures Postherpetic Neuralgia Prevention And Treatment Of Perioperative Seizures Primary Generalized Tonic-clonic Seizures Primary Generalized Tonic-clonic Seizures (adjunctive) Restless Leg Syndrome (Horizant Formulation) Sedation (perioperative) Spinal Cord Injury Neuropathic Pain Status Epilepticus Status Epilepticus (IV) Tonic-clonic Seizures Trigeminal Neuralgia
antifungal 36 terms
Antifungal Antifungal Prophylaxis During Allogeneic HSCT Antifungal Prophylaxis In High-risk Immunocompromised Patients Antifungal Prophylaxis In HSCT Recipients Aspergillosis (prophylaxis And Treatment) Blastomycosis Candida UTI Candidemia (non-neutropenic — Second-line After Echinocandin) Candidemia/invasive Candidiasis (alternative) Cryptococcal Meningitis (consolidation/maintenance Therapy) Cryptococcal Meningitis (in HIV — With Flucytosine) Echinocandin Antifungal Empiric Antifungal Therapy In Febrile Neutropenia Esophageal Candidiasis Histoplasmosis Histoplasmosis And Other Endemic Mycoses (severe Or Disseminated) Invasive Aspergillosis (alternative To Voriconazole) Invasive Aspergillosis (first-line) Invasive Aspergillosis (primary Or Salvage) Invasive Aspergillosis (salvage Therapy) Invasive Aspergillosis Prophylaxis (high-risk Patients: AML Remission Induction, GVHD) Invasive Candidiasis Invasive Candidiasis/candidemia Invasive Candidiasis/candidemia (first-line) Invasive Mucormycosis Mucormycosis (liposomal Preferred) Mucormycosis (prophylaxis And Salvage Therapy) Onychomycosis Oropharyngeal And Esophageal Candidiasis Oropharyngeal Candidiasis (refractory Or In Immunocompromised) Paracoccidioidomycosis Polyene Antifungal Antibiotic Scedosporiosis, Fusariosis (salvage Therapy) Sporotrichosis Triazole Antifungal Vulvovaginal Candidiasis (single 150 Mg Dose)
antihypertensive 89 terms
ACE Inhibitor Acute Aortic Dissection (after Beta-blocker) Acute HF With Severe Afterload Increase Acute MI (IV) ADHD (children 6-17 Years, Monotherapy Or Adjunct) ADHD (Kapvay) ADHD (monotherapy Or Adjunct To Stimulants In Children 6-17 Years) AF Rate Control Alopecia (topical) Alpha-1 Blocker Alpha-2 Adrenergic Agonist Alpha-2A Adrenergic Agonist Angina Angina (XL/IR) Angiotensin II Receptor Blocker (ARB) Angiotensin Receptor-neprilysin Inhibitor (ARNI) Asymptomatic LV Dysfunction Atrial Fibrillation (rate Control) Atrial Flutter Benign Prostatic Hyperplasia (BPH) Beta-blocker Bipolar Disorder (adjunct) BPH Calcium Channel Blocker Cancer Pain (epidural, Duraclon) Cardiovascular Risk Reduction (HOPE Trial) Cardiovascular Risk Reduction (ONTARGET) Central Alpha-2 Agonist Chronic Heart Failure (HFrEF) Chronic Stable Angina CKD (non-diabetic) Cluster Headache Prophylaxis Controlled Hypotension During Surgery Coronary Artery Disease Diabetic Nephropathy Diabetic Nephropathy In Type 2 Diabetes Diabetic Nephropathy In Type 2 Diabetes With Hypertension Direct Vasodilator Direct Vasodilator / Potassium Channel Activator Essential Tremor Heart Failure Heart Failure (ACE-I Intolerant) Heart Failure (combined With Isosorbide Dinitrate In Black Patients) Heart Failure (HFrEF, CIBIS-II) Heart Failure (HFrEF) Heart Failure (NYHA Class II-IV) Heart Failure (post-MI) Heart Failure Post-MI HFrEF (EF ≤40%) HOCM Hypertension Hypertension (adjunct) Hypertension (XL) Hypertension In Pregnancy Hypertension In Pregnancy (IV) Hypertensive Emergency (IR Sublingual — No Longer Recommended Due To Unpredictable Hypotension) Hypertensive Emergency (IV) Hypertensive Emergency (rapid Titration) Hypertensive Urgency/emergency (IV) Hyperthyroidism (thyroid Storm) LVH Reduction Marfan Syndrome (off-label) Menopausal Hot Flashes Migraine Prophylaxis Off-label: ADHD In Adults Off-label: Opioid Withdrawal Adjunct Off-label: PTSD-related Hyperarousal And Nightmares Off-label: PTSD-related Nightmares And Hyperarousal Off-label: Tic Disorders (Tourette Syndrome) Off-label: Tourette Syndrome Opioid/alcohol Withdrawal Adjunct Performance Anxiety Pheochromocytoma (after Adequate Alpha Block) Pheochromocytoma (after Alpha-blocker) Pheochromocytoma (short-term Perioperative) Pheochromocytoma Perioperative Management Portal Hypertension (varices) Post-MI Post-MI Cardioprotection Post-MI LV Dysfunction Preterm Labor (tocolysis, Off-label) PSVT (IV) PTSD-associated Nightmares (off-label) Raynaud's Phenomenon Severe/resistant Hypertension (oral) Symptomatic NYHA Class II-IV Heart Failure Tourette Syndrome Vasospastic (Prinzmetal) Angina Vasospastic Angina
antilipemic 46 terms
Acromegaly (excess GH/IGF-1) Adjunct In Patients At High Cardiovascular Risk Antilipemic Agent — Niacin ASCVD (secondary Prevention) ASCVD Prevention Atherosclerotic Cardiovascular Disease (ASCVD) Atherosclerotic Cardiovascular Disease With Elevated LDL-C Inadequately Controlled By Maximally Tolerated Statin Therapy Carcinoid Syndrome (VIPoma, Glucagonoma, Gastrinoma) Cardiovascular Risk Reduction Cardiovascular Risk Reduction In Patients With Elevated Triglycerides On Maximally Tolerated Statin Therapy With Established CVD Or Diabetes Plus 2 Or More CVD Risk Factors Cholesterol Absorption Inhibitor Cushing's Disease (off-label) Diarrhea/flushing From Neuroendocrine Tumors Familial Hypercholesterolemia Fibrate Fredrickson Types IIb, III, IV, V Heterozygous Familial Hypercholesterolemia Heterozygous Or Homozygous Familial Hypercholesterolemia HMG-CoA Reductase Inhibitor (statin) Homozygous Familial Hypercholesterolemia Hypercholesterolemia Hyperlipidemia Hyperlipidemia (adjunct To Statin) Hyperlipidemia (primary Prevention + Secondary Prevention) Hypertriglyceridemia Hypertriglyceridemia (adjunct) LDL Reduction Uncontrolled On Statins Low HDL Cholesterol Mixed Dyslipidemia Mixed Dyslipidemia (high TG, Low HDL) Omega-3 Fatty Acid Cardiovascular Agent PCSK9 Inhibitor Primary Hyperlipidemia Primary Hyperlipidemia Uncontrolled On Statins Primary Prevention Of Cardiovascular Events In Select Patients Refractory Hypoglycemia (insulinoma) Secondary Prevention In Type IIb Dyslipidemia (Helsinki Heart Study) Secondary Prevention Of Cardiac Events Post-PCI Secondary Prevention Of CV Events Severe Hypertriglyceridemia (500 Mg/dL Or Greater) Sitosterolemia Small Interfering RNA (siRNA) — PCSK9 Inhibitor Somatostatin Analog Statin Transplant Patients (fewer Drug Interactions) Variceal Bleeding (portal Hypertension)
antimigraine 19 terms
Acute Migraine (historical; Now Largely Replaced By Triptans Due To Superior Tolerability) Acute Migraine (with Or Without Aura) Acute Migraine With Or Without Aura Acute Treatment Of Migraine With Or Without Aura (adults) Anti-CGRP Monoclonal Antibody Anti-CGRP Receptor Monoclonal Antibody Antimigraine CGRP Receptor Antagonist (gepant) Cluster Headache (SC Formulation) Cluster Headache (second-line) Ergot Alkaloid / Vasoconstrictor Preventive Treatment Of Chronic Migraine (adults — FDA Approved 2023) Preventive Treatment Of Episodic Cluster Headache (adults) Preventive Treatment Of Episodic Migraine (adults) Preventive Treatment Of Episodic Migraine (adults) — First Oral Drug Approved For Both Acute And Preventive Migraine In Same Formulation Preventive Treatment Of Migraine In Adults Preventive Treatment Of Migraine In Adults (episodic And Chronic) Serotonin 5-HT1F Receptor Agonist (ditan) Triptan (serotonin 5-HT1B/1D Agonist)
antineoplastic 77 terms
Acute Leukemias Acute Lymphoblastic Leukemia (ALL) — Cornerstone Acute Lymphoblastic Leukemia (Ph+ ALL) Acute Myeloid Leukemia (AML) — In Combination With Azacitidine Or Decitabine, Or Low-dose Cytarabine (in Adults Ineligible For Intensive Induction) Advanced/metastatic Melanoma ALL (cornerstone) ANCA-associated Vasculitis (immunosuppression) Anthracycline Antineoplastic Antibiotic Anti-CD20 Monoclonal Antibody Antimetabolite Antineoplastic BCL-2 Inhibitor BCR-ABL Tyrosine Kinase Inhibitor Bladder Cancer Bladder, Ovarian, Thyroid Cancers Breast Cancer Breast Cancer (adjuvant And Metastatic) Cervical Cancer Choriocarcinoma Chronic Lymphocytic Leukemia (CLL) Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma (CLL/SLL) Chronic Myeloid Leukemia (CML) — Cytoreduction, Now Largely Replaced By TKIs Chronic Myeloid Leukemia (CML) — Standard First-line For Ph+ CML CNS Prophylaxis (intrathecal) Ectopic Pregnancy (intramuscular) Essential Thrombocythemia Follicular Lymphoma Gastric/esophageal Cancer Gastrointestinal Stromal Tumor (GIST) — C-KIT Driven Granulomatosis With Polyangiitis/microscopic Polyangiitis (ANCA Vasculitis) Head And Neck Cancer Head And Neck Cancer (with Radiation As Radiosensitizer) Head And Neck Squamous Cell Carcinoma Hematopoietic Stem Cell Transplant Conditioning Hodgkin And Non-Hodgkin Lymphoma Hodgkin Lymphoma Immunomodulatory Imide Drug (IMiD) Kaposi Sarcoma Kaposi Sarcoma (liposomal Formulation) Lung Cancer (NSCLC And SCLC) Lupus Nephritis Mantle Cell Lymphoma Mantle Cell Lymphoma (maintenance After Autologous HSCT) MSI-high/dMMR Solid Tumors (tumor-agnostic Approval) Multiple Myeloma Multiple Myeloma (front-line And Relapsed/refractory) Multiple Myeloma (with Dexamethasone Or With Bortezomib+dexamethasone) Myelodysplastic Syndrome (5q Deletion — Del(5q) MDS) Nephrotic Syndrome Neuroblastoma Nitrogen Mustard Alkylating Agent Non-Hodgkin Lymphoma Non-Hodgkin Lymphoma (CD20+) NSCLC (PD-L1 Positive) NSCLC (with Carboplatin) Osteosarcoma Ovarian Cancer Ovarian Cancer (first-line With Carboplatin) Pancreatic Cancer (nab-paclitaxel + Gemcitabine) PD-1 Checkpoint Inhibitor Monoclonal Antibody Pemphigus Vulgaris Platinum-based Alkylating Agent Polycythemia Vera Proteasome Inhibitor Antineoplastic Psoriasis (low Dose) Rhabdomyosarcoma Rheumatoid Arthritis (low Dose) Rheumatoid Arthritis (with Methotrexate, After Anti-TNF Failure) Sickle Cell Disease (reduces Painful Crises And Acute Chest Syndrome) Small Cell Lung Cancer Soft Tissue Sarcoma Taxane Antineoplastic Testicular Cancer (curative) TMB-high Solid Tumors Triple-negative Breast Cancer Urothelial Carcinoma Vinca Alkaloid Antineoplastic Wilms Tumor
antiparasitic 24 terms
Aminoquinoline Antiparasitic Aminoquinoline Antiparasitic/DMARD Ascariasis, Hookworm, Pinworm, Whipworm (standard Intestinal Helminths) Benzimidazole Antiparasitic Combination Antimalarial Cystic Echinococcosis (hydatid Disease) Extraintestinal Amebiasis Filariasis Giardiasis (alternative) Lupus And Rheumatoid Arthritis (at Lower Doses — Replaced By Hydroxychloroquine) Lymphatic Filariasis (mass Drug Administration) Macrocyclic Lactone Antiparasitic Malaria Prophylaxis And Treatment (chloroquine-sensitive) Malaria Prophylaxis For Travelers To Chloroquine-resistant Regions Malaria Treatment (P. Falciparum Including Chloroquine-resistant) Malaria Treatment And Prophylaxis — Chloroquine-sensitive Plasmodium (primarily P. Vivax And P. Ovale In Non-resistant Areas) Neurocysticercosis (Taenia Solium) Onchocerciasis (river Blindness) — Microfilaricidal Pediculosis (lice) — For Treatment-resistant Cases Rheumatoid Arthritis (DMARD) Scabies (including Crusted/Norwegian Scabies) Sjögren's Syndrome Strongyloidiasis Systemic Lupus Erythematosus (SLE) — Reduces Flares And Mortality
antiparkinsonian 19 terms
Amyotrophic Lateral Sclerosis (ALS) — Delays Disease Progression And Extends Tracheostomy-free Survival Anticholinergic Antiparkinson Agent Antiparkinsonian COMT Inhibitor Dopa-responsive Dystonia Dopamine Agonist Drug-induced Extrapyramidal Symptoms (particularly Acute Dystonia And Parkinsonism) Moderate To Severe Restless Legs Syndrome Monoamine Oxidase B Inhibitor (MAO-B Inhibitor) Neuroprotective Agent / Glutamate Antagonist Off-label: Hypersalivation In Antipsychotic-treated Patients Parkinson's Disease (early And Advanced, As Monotherapy Or Adjunct To Levodopa) Parkinson's Disease (early And Advanced) Parkinson's Disease (gold Standard Symptomatic Treatment) Parkinson's Disease (mild Cases Or Adjunct) Parkinson's Disease (monotherapy Early-stage Or Adjunct To Levodopa) Parkinson's Disease With End-of-dose Motor Fluctuations (wearing Off) As Adjunct To Levodopa/carbidopa Restless Leg Syndrome (off-label) Restless Legs Syndrome (moderate To Severe)
antiplatelet 27 terms
ACS (NSTEMI, STEMI) — PLATO Trial Preference Over Clopidogrel ACS With DAPT (dual Antiplatelet Therapy) ACS With Planned PCI (TRITON-TIMI 38) Acute Coronary Syndromes (NSTEMI/unstable Angina) In Patients Undergoing PCI Or Managed Medically Acute Coronary Syndromes (NSTEMI/unstable Angina) Managed Medically Or With PCI Adjunct To PCI (elective Or Urgent) Adjunct To PCI In High-risk Coronary Interventions Anti-inflammatory (high Dose) Antiplatelet Antiplatelet (CV Secondary Prevention, ACS, Stroke/TIA) Antiplatelet / NSAID Antiplatelet Agent Antiplatelet Agent — Phosphodiesterase III Inhibitor Glycoprotein IIb/IIIa Inhibitor Kawasaki Disease PAD Pain And Fever (higher Doses) PCI Stent Thrombosis Prevention Pharmacologic Cardiac Stress Testing (IV Formulation) Preeclampsia Prevention (low-dose) Prevention Of Stroke And TIA (combined With Aspirin As Aggrenox) Prosthetic Heart Valve Thromboprophylaxis (with Warfarin) Secondary Prevention In CAD Stroke/TIA Prevention Stroke/TIA Prevention (SOCRATES) Symptomatic Intermittent Claudication (peripheral Arterial Disease) Unstable Angina Not Responding To Conventional Therapy When PCI Planned Within 24 Hours
antipsychotic 48 terms
Acute Agitation Acute Agitation (IM Formulation) Acute Agitation In Schizophrenia (IM) Acute Psychosis / Agitation Adjunct For Major Depressive Disorder (FDA-approved 2023) Adjunct To Antidepressants For Major Depressive Disorder Agitation Associated With Alzheimer's Dementia (FDA-approved 2023) Agitation In Schizophrenia (IM) Agitation In Schizophrenia/bipolar (IM) Anti-emesis In Palliative Care Anticholinergic Effects Antiemetic / Antipsychotic Antipsychotic Atypical Antipsychotic Bipolar Depression (FDA-approved) Bipolar Depression (Seroquel XR) Bipolar I Depression (as Monotherapy Or Adjunct To Lithium/valproate) Bipolar I Depression (with Fluoxetine — Symbyax) Bipolar I Disorder (acute Mania And Maintenance) Bipolar I Disorder (mania And Maintenance) Bipolar I Mania Bipolar I Mania (acute) Bipolar I Mania And Mixed Episodes Delirium (IV/IM) First-generation Antipsychotic (FGA) Generalized Anxiety Disorder (off-label) Hallucinations And Delusions Associated With Parkinson's Disease Psychosis Intractable Hiccups Irritability Associated With Autism Spectrum Disorder Long-acting Injectable (LAI) Formulations For Maintenance Therapy Major Depressive Disorder (adjunct) Migraine Headache (acute — Adjunct) Nausea And Vomiting Nausea/vomiting Off-label: Mania Off-label: Tourette Syndrome Pigmentary Retinopathy QT Prolongation Reducing Suicidal Behavior In Patients With Schizophrenia Or Schizoaffective Disorder Schizoaffective Disorder Schizophrenia Second-generation Antipsychotic (SGA) Tardive Dyskinesia Torsades De Pointes Tourette's Syndrome Treatment-resistant Schizophrenia (defined As Failure Of ≥2 Adequate Antipsychotic Trials) Treatment-resistant Schizophrenia (second-line) Vertigo
antiretroviral 21 terms
Antiretroviral CCR5 Co-receptor Antagonist (entry Inhibitor) Chronic Hepatitis B (HBV) Treatment Component Of Preferred Initial Antiretroviral Regimens Hepatitis B Infection (also Active) HIV Integrase Strand Transfer Inhibitor (INSTI) HIV Pre-exposure Prophylaxis (PrEP) In Combination With Emtricitabine HIV Protease Inhibitor (PI) HIV-1 Infection (as Part Of Combination ART — Virtually Always In Combination, Not Used Alone) HIV-1 Infection (as Part Of Combination ART) HIV-1 Infection (in Combination ART With Ritonavir Or Cobicistat Boosting) HIV-1 Infection (in Combination ART) — Particularly In Patients Who Cannot Tolerate Tenofovir Due To Renal Or Bone Disease HIV-1 Infection (part Of Combination ART Regimen) HIV-1 Infection (treatment-naïve And Experienced) HIV-1 Infection (treatment-naive And Treatment-experienced Adults And Children ≥4 Weeks) HIV-1 Infection (treatment-naïve And Treatment-experienced Patients) — Must Be Given With Ritonavir Or Cobicistat Boosting HIV-1 Infection In Pregnant Women Near Delivery (rapid ART Initiation) HIV-1 Infection In Treatment-experienced Patients With CCR5-tropic Virus Only (after Tropism Testing Confirms CCR5-only Tropism) Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Nucleoside Reverse Transcriptase Inhibitor (NRTI) Nucleotide Reverse Transcriptase Inhibitor (NtRTI)
antithyroid 13 terms
Antithyroid Antithyroid Agent / Iodine Supplement Expectorant (off-label) Hyperthyroidism (Graves' Disease — First-line Antithyroid Therapy) Hyperthyroidism (Graves' Disease) Pregnancy Hyperthyroidism (first Trimester Preferred Over Methimazole) Preoperative Preparation For Thyroidectomy (reduce Vascularity And Hormone Release) Preparation For Thyroid Surgery Or Radioiodine Therapy Radiation Emergency (blocking Thyroid Uptake Of Radioactive Iodine) Thionamide Thyroid Storm (drug Of Choice) Thyroid Storm (high Doses) Thyroid Storm (in Combination With PTU And Beta-blocker)
antiviral 45 terms
Acute Uncomplicated Influenza In Adults (single IV Dose When Patient Cannot Take Oral Drugs) Acute Uncomplicated Influenza In Adults And Pediatric Patients (≥5 Years Or ≥20 Kg, Or High-risk) Acyclovir-resistant HSV Or VZV Infections Antiviral Antiviral — Acyclovir Prodrug Antiviral — CMV Terminase Inhibitor Antiviral — Ganciclovir Prodrug Antiviral — Guanosine Analog Antiviral — Penciclovir Prodrug Antiviral — Pyrophosphate Analog Antiviral / Antiparkinson Agent Cap-dependent Endonuclease Inhibitor Antiviral Chickenpox (VZV) In Immunocompromised CMV Disease In Immunocompromised Patients Refractory To Ganciclovir CMV Disease Prevention In Pediatric Kidney And Heart Transplant Recipients CMV Disease Prevention In Solid Organ Transplant Recipients CMV Disease Prophylaxis In Transplant Recipients (usually As IV Bridge Before Switching To Oral Valganciclovir) CMV Esophagitis/colitis CMV Prophylaxis In Adult CMV-seropositive Recipients Of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) CMV Prophylaxis In Transplant Recipients (high Doses) CMV Retinitis (acyclovir- Or Ganciclovir-refractory) CMV Retinitis In AIDS Patients CMV Retinitis Treatment In AIDS (induction And Maintenance) Drug-induced Extrapyramidal Symptoms Genital Herpes — Episodic Treatment And Suppression Genital Herpes — Initial And Recurrent Episodes And Suppression H5N1 Avian Influenza (treatment And Prophylaxis) Herpes Labialis (cold Sores) — Episodic Treatment And Suppression Herpes Labialis (cold Sores) In Immunocompetent Adults Herpes Simplex Virus (HSV) Infections: Genital Herpes (treatment/suppression), Herpes Labialis, Mucocutaneous HSV Herpes Zoster (shingles) HHV-6 And HHV-8 Infections HSV Encephalitis (IV — First-line) Influenza A And B Treatment (within 48 Hours Of Symptom Onset) Influenza A Prophylaxis/treatment (historical; Now Largely Replaced By Oseltamivir) Influenza Prophylaxis (post-exposure And Seasonal) Influenza Prophylaxis (post-exposure) Levodopa-induced Dyskinesia (ER Formulation) Neonatal HSV (IV) Neuraminidase Inhibitor Antiviral Parkinson's Disease (adjunct For Motor Symptoms) Prophylaxis Of Influenza A And B In Household Contacts Treatment Of Influenza A And B (initiated Within 48 Hours Of Symptom Onset) Treatment Of Serious Influenza In Hospitalized Patients (regardless Of Symptom Duration) Varicella (chickenpox)
anxiolytic 2 terms
Behavioral Health 23 terms
Active Listening Affirmations Ambivalence Behavior Change Change Talk Collaborative Communication Contemplation Stage Decisional Balance Empathy Evocation Motivational Interviewing OARS Open-Ended Questions Precontemplation Reflective Listening Resistance Rolling With Resistance Self-Efficacy Stages Of Change Summaries Sustain Talk Therapeutic Alliance Transtheoretical Model
benzodiazepine 20 terms
Acute Agitation Acute Alcohol Withdrawal Acute Repetitive Seizures Alcohol Withdrawal Anesthesia Induction/maintenance Anxiety Associated With Depression Anxiety Disorders Benzodiazepine Chemotherapy-induced Nausea (adjunct) Generalized Anxiety Disorder (GAD) ICU Sedation Muscle Spasm Panic Disorder Preoperative Sedation Procedural Sedation And Anxiolysis Procedural Sedation/amnesia Short-term Treatment Of Insomnia Status Epilepticus (first-line IV Treatment) Status Epilepticus (IM, Intranasal, Buccal) Status Epilepticus (IV/rectal)
biologic 26 terms
Atopic Dermatitis (moderate-severe) Biologic — Anti-IgE Monoclonal Antibody Biologic — Anti-IL-4/IL-13 Monoclonal Antibody Biologic — Anti-interleukin-5 (anti-IL-5) Monoclonal Antibody Biologic — Anti-interleukin-5 Receptor Alpha (anti-IL-5Ralpha) Monoclonal Antibody Biologic — Anti-thymic Stromal Lymphopoietin (anti-TSLP) Monoclonal Antibody Chronic Idiopathic Urticaria Chronic Rhinosinusitis With Nasal Polyps Effective In Eosinophilic And Non-eosinophilic Asthma Phenotypes Eosinophilic Esophagitis Eosinophilic Granulomatosis With Polyangiitis (EGPA) Hypereosinophilic Syndrome (HES) IL-12/IL-23 Inhibitor (monoclonal Antibody) Integrin Receptor Antagonist (gut-selective Biologic) Moderate To Severely Active Crohn's Disease Moderate To Severely Active Ulcerative Colitis Moderate-severe Allergic Asthma (IgE-mediated; Baseline IgE 30-700 IU/mL) Moderate-severe Eosinophilic Asthma Or OCS-dependent Asthma Nasal Polyps Plaque Psoriasis Prurigo Nodularis Psoriatic Arthritis Severe Eosinophilic Asthma (add-on Maintenance Therapy, Adults 18 Years Or Older) Severe Eosinophilic Asthma (add-on Maintenance Therapy, Adults And Adolescents 12 Years Or Older) Severe Eosinophilic Asthma (add-on Maintenance, Adults And Children 6 Years Or Older) Severe Uncontrolled Asthma As Add-on Maintenance Therapy (adults And Adolescents 12 Years And Older)
bone agent 19 terms
Bisphosphonate Bone Metastases (Xgeva: Giant Cell Tumor, Solid Tumors, Multiple Myeloma) Bone Metastases Prevention (Zometa: Multiple Myeloma, Solid Tumors) Calcimimetic Glucocorticoid-induced Osteoporosis Male Osteoporosis Malignant Hypercalcemia Osteoporosis (postmenopausal Women) Osteoporosis (Prolia: Postmenopausal Women, Men, Glucocorticoid-induced) Osteoporosis (Reclast: 5 Mg IV Once Yearly) Osteoporosis In Men Osteoporosis In Postmenopausal Women At High Fracture Risk Paget's Disease Of Bone Parathyroid Carcinoma Parathyroid Hormone Analog Prevention Of Skeletal-related Events In Malignancy Primary Hyperparathyroidism (inoperable) RANK Ligand (RANKL) Inhibitor Secondary Hyperparathyroidism In Dialysis Patients With CKD
bronchodilator 29 terms
Acute Bronchospasm (asthma, COPD Exacerbation) Acute Bronchospasm (asthma, COPD) Acute Severe Asthma (adjunct To SABA) Apnea Of Prematurity (IV Aminophylline) Asthma (add-on — Third-line) Asthma (adjunct In Uncontrolled Disease) Asthma Maintenance (with ICS — Never Monotherapy) Asthma Maintenance (with ICS Only — Never Monotherapy) Asthma Maintenance Therapy (with Fluticasone Furoate As Breo Ellipta) Beta-2 Adrenergic Agonist (LABA) Beta-2 Adrenergic Agonist (SABA) Bronchodilator Chronic COPD Maintenance COPD COPD (add-on) COPD (first-line) COPD Exacerbation COPD Maintenance COPD Maintenance Bronchodilator Therapy COPD Maintenance Bronchodilator Therapy (not Indicated For Asthma) COPD Maintenance Therapy (with Umeclidinium As Anoro Ellipta) COPD With Comorbid Asthma Exercise-induced Bronchospasm Hyperkalemia (IV/nebulized) Methylxanthine Muscarinic Receptor Antagonist (LAMA) Prevention Of Exercise-induced Bronchospasm Rhinorrhea (intranasal) Used As Rescue In ICS-formoterol Combination (GINA Preferred Reliever)
cardiac glycoside 3 terms
Cardiac Monitoring 22 terms
Amiodarone Antiarrhythmics Antipsychotics Azithromycin Cardiac Monitoring Corrected QT Interval Defibrillation Electrolyte Imbalance Fluoroquinolones Haloperidol Hypocalcemia Hypokalemia Hypomagnesemia Long QT Syndrome Methadone Ondansetron QT Interval Repolarization Sotalol Sudden Cardiac Death Torsades De Pointes Twelve-Lead ECG
Cardiovascular 151 terms
ACC/AHA Guidelines Ace Inhibitors ACLS Acquired Long QT Syndrome Acute Decompensated Heart Failure Acute Fluid Retention Acute Kidney Injury Aldosterone Almost-Right Answer Alpha-Blockers Amiodarone Amlodipine Angiotensin II Antiarrhythmics Antipsychotics ARBs Atenolol Autonomic Nervous System Azithromycin Bazett's Formula Beers Criteria Beta-Blockers Bilateral Basilar Crackles BiPAP Calcium Calcium Channel Blockers Calcium Gluconate Cardiac Action Potential Cardiac Output Cardiac Repolarization Cardiac Telemetry Cardiopulmonary Resuscitation Carvedilol Cinchonism Ciprofloxacin CJMM Clinical Decision Support Clonidine Compassion Trap Congenital Long QT Syndrome Corrected QT Interval Crash Cart CredibleMeds Defibrillation Defibrillator Depolarization Diastolic Blood Pressure Digoxin Digoxin Toxicity Diphenhydramine Diuretic Resistance Diuretic-Induced Electrolyte Imbalance Documentation Dofetilide Droperidol ECG Electrolyte Panel Electrolyte Replacement Electrolytes Electronic Health Record Erythromycin Evidence-Based Practice Flash Pulmonary Edema Fluoroquinolones Furosemide GFR Haloperidol Heart Failure Heart Failure with Reduced Ejection Fraction HERG Gene High-Alert Medications Hydralazine Hydrochlorothiazide Hypertension Hypertensive Crisis Hypocalcemia Hypokalemia Hypokalemia-Induced Cardiac Arrhythmia Hypomagnesemia Hypotension ICD IKr Blockade IKr Potassium Channel Incident Report ISMP Isoproterenol IV Magnesium Sulfate Jugular Venous Distension Levofloxacin Lisinopril Long QT Syndrome Loop Diuretics Losartan LQT1 LQT2 LQT3 Magnesium MAP Medication Reconciliation Methadone Mexiletine Moxifloxacin Na+/K+-ATPase NGN Nifedipine Ondansetron Orthopneic Positioning Orthostatic Hypotension Overdrive Pacing Palpitations Patient Education Peripheral Vascular Resistance Pitting Edema Polymorphic Ventricular Tachycardia Polypharmacy Potassium Potassium Replacement Potassium Supplementation Preeclampsia Premature Ventricular Contractions Prerenal Azotemia Protocol Shortcut Pulmonary Edema QSEN QT Interval QT Prolongation QTc Monitoring Quetiapine Quinidine R-on-T Phenomenon Rapid Response REMS Renal Impairment Renin-Angiotensin-Aldosterone System Repolarization SBAR Sotalol Sudden Cardiac Death Syncope Systolic Blood Pressure T-wave Morphology Telemetry Thiazide Diuretics Thioridazine Torsades De Pointes Twelve-Lead ECG Valsartan Ventricular Fibrillation Ventricular Tachycardia Volume Depletion Ziprasidone
CFTR modulator 5 terms
Also Indicated For Patients With Other CFTR Mutations Responsive To Elexacaftor Based On Clinical And/or In Vitro Data CFTR Modulator — Triple Combination CFTR Potentiator Cystic Fibrosis In Patients 4 Months And Older With At Least One CFTR Gating Mutation (e.g., G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, S549R) Or Other Responsive Mutations Per FDA-approved List Cystic Fibrosis In Patients Aged 2 Years And Older With At Least One F508del Mutation In The CFTR Gene (approximately 85% Of CF Patients)
Clinical Communication 23 terms
Active Listening Affirmations Ambivalence Behavior Change Change Talk Collaborative Communication Contemplation Stage Decisional Balance Empathy Evocation Motivational Interviewing OARS Open-Ended Questions Precontemplation Reflective Listening Resistance Rolling With Resistance Self-Efficacy Stages Of Change Summaries Sustain Talk Therapeutic Alliance Transtheoretical Model
Clinical Judgment 37 terms
Adverse Drug Reaction AVPU Barcode Medication Administration Brain Sheet Clinical Assessment Code Status Documentation Double-Check Fall Prevention Fall Risk Glasgow Coma Scale Head-To-Toe Assessment Hendrich II Heparin High-Alert Medications Incident Report Independent Double-Check Informed Refusal Insulin IV Site Assessment MAR Medication Error Near Miss Patient Identification Patient Safety Phlebitis Polypharmacy Potassium Chloride PQRSTU Prioritization PRN Order SBAR Scheduled Medication Shift Handoff STAT Order Time Management Triage
CNS stimulant 8 terms
corticosteroid 53 terms
Acute Asthma Exacerbation (outpatient Single Dose) Adrenal Crisis (IV) Adrenal Insufficiency (primary And Secondary) — First-choice For Physiologic Replacement Adrenal Insufficiency (with Fludrocortisone) Adrenal Insufficiency Testing (dexamethasone Suppression Test) Allergic Reactions And Anaphylaxis (adjunct) Allergic Rhinitis Allergic Rhinitis (nasal Formulation) Allergic Rhinitis (nasal Spray) Allergic Rhinitis (nasal) Anaphylaxis (adjunct After Epinephrine) Anaphylaxis (secondary To Epinephrine) Antenatal Fetal Lung Maturation (prematurity 24–34 Weeks Gestation) Anti-emetic (CINV — High-dose) Asthma Exacerbations Asthma Maintenance Asthma Maintenance (ICS — First-line) Asthma Maintenance And Prevention Of Symptoms Asthma Maintenance Therapy Autoimmune Diseases (multiple Sclerosis, SLE, IBD Flares) Autoimmune Diseases (rheumatoid Arthritis, Lupus, IBD, Vasculitis) Cerebral Edema Cerebral Edema (brain Tumors, Head Injury) Cerebral Edema (IV Dexamethasone Preferred For Brain Tumors) Cerebral Edema Reduction CINV Prevention (first-line Component) COPD (combined With Formoterol) COPD Exacerbations COPD With Frequent Exacerbations (combined With LABA) COPD With Frequent Exacerbations (in Combination Products) Corticosteroid COVID-19 (patients Requiring Oxygen — RECOVERY Trial) Crohn Disease (oral, Enteral — Different Indication) Croup (single IM/oral Dose) Inflammatory And Autoimmune Conditions Inhaled Corticosteroid Inhaled Corticosteroid (ICS) Intra-articular Inflammation Mineralocorticoid Multiple Myeloma (component Of Treatment Regimens) Organ Transplant Rejection Prophylaxis Orthostatic Hypotension (off-label) Persistent Asthma (all Severity Levels, Maintenance Therapy) Persistent Asthma (maintenance Therapy In Patients Aged 4 Years And Older) Persistent Asthma In Adults And Adolescents (inhaled) Primary Adrenal Insufficiency (Addison's Disease) — Mineralocorticoid Replacement Salt-losing Congenital Adrenal Hyperplasia Septic Shock (low-dose Adjunctive — Refractory Shock) Septic Shock (physiologic Doses) Severe Acute Asthma Exacerbations (IV) Severe Inflammation Or Immune Reactions Spinal Cord Injury (historical; No Longer Standard Of Care) Transplant Rejection Prophylaxis
Critical Care 27 terms
Analyze Cues Anchoring Bias Blood Cultures Broad-Spectrum Antibiotics Cefazolin Clinical Judgment Measurement Model Crystalloid Resuscitation Evaluate Outcomes Hour-1 Bundle Hypothermia Lactate Mean Arterial Pressure Multi-Organ Failure Norepinephrine Quick SOFA Recognize Cues SBAR Sepsis Sepsis-3 Septic Shock Sequential Organ Failure Assessment SOFA Score Surviving Sepsis Campaign Systemic Inflammatory Response Syndrome Take Action Vasodilatory Shock Vasopressor
D442 60 terms
Active Listening Adverse Drug Reaction Affirmations Ambivalence AVPU Barcode Medication Administration Behavior Change Brain Sheet Change Talk Clinical Assessment Code Status Collaborative Communication Contemplation Stage Decisional Balance Documentation Double-Check Empathy Evocation Fall Prevention Fall Risk Glasgow Coma Scale Head-To-Toe Assessment Hendrich II Heparin High-Alert Medications Incident Report Independent Double-Check Informed Refusal Insulin IV Site Assessment MAR Medication Error Motivational Interviewing Near Miss OARS Open-Ended Questions Patient Identification Patient Safety Phlebitis Polypharmacy Potassium Chloride PQRSTU Precontemplation Prioritization PRN Order Reflective Listening Resistance Rolling With Resistance SBAR Scheduled Medication Self-Efficacy Shift Handoff Stages Of Change STAT Order Summaries Sustain Talk Therapeutic Alliance Time Management Transtheoretical Model Triage
diuretic 49 terms
Acne/hirsutism (off-label, Antiandrogen) Acute Hemolytic Transfusion Reaction (forced Diuresis) Acute Pulmonary Edema Altitude Sickness Prophylaxis Autosomal Dominant Polycystic Kidney Disease (Jynarque — TEMPO 3:4 Trial) Carbonic Anhydrase Inhibitor Central Sleep Apnea Cerebral Edema (increased ICP) Chronic Heart Failure CKD With Type 2 Diabetes (FIDELIO-DKD, FIGARO-DKD) Edema Edema (cirrhosis, Nephrotic Syndrome) Edema (diuretic-resistant) Edema (hepatic, Renal, Cardiac) Edema (weak, Rarely Used) Edema (with Thiazide/loop) Epilepsy (adjunct) Euvolemic Hyponatremia (SIADH) Heart Failure Heart Failure (HFrEF — RALES Trial) Heart Failure With Diuretic Resistance HFrEF (FINEARTS-HF, Emerging) HFrEF Post-MI (EPHESUS) Hyperaldosteronism Hypercalcemia Hypertension Hypertension (adjunct) Hypertension (resistant) Hypervolemic Hyponatremia (heart Failure, Cirrhosis) — Hospitalized Patients Hypokalemia Prevention Hypokalemia Prevention (combination With Thiazides) Hyponatremia (SIADH, Hypervolemic Hyponatremia In HF/cirrhosis) Idiopathic Intracranial Hypertension Lithium-induced Nephrogenic Diabetes Insipidus (off-label) Loop Diuretic Metabolic Alkalosis (adjunct) Mineralocorticoid Receptor Antagonist Nephrogenic Diabetes Insipidus (paradoxical) Nephrolithiasis (calcium Oxalate, Hypercalciuria) Oliguric Renal Failure (flush) Open-Angle Glaucoma Osmotic Diuretic Potassium-sparing Diuretic Potassium-sparing Diuretic / Mineralocorticoid Receptor Antagonist Renal Failure Diuresis Rhabdomyolysis (forced Diuresis) Thiazide Diuretic Thiazide-like Diuretic Vasopressin Receptor Antagonist (vaptans)
electrolyte agent 14 terms
Alkalinizing Agent Antacid Cardiac Arrest (specific Situations: TCA Toxicity, Hyperkalemia With Dysrhythmia) Chronic CKD-associated Metabolic Acidosis (oral) Hyperkalemia (acute And Chronic Management) Hyperkalemia (chronic — Especially In CKD With RAAS Inhibitor Use) Hyperkalemia With Cardiac Toxicity (cardioprotection Via Membrane Stabilization) Hyperphosphatemia In Chronic Kidney Disease (both Dialysis And Non-dialysis Patients) Hyperphosphatemia In End-stage Renal Disease (dialysis Patients) Metabolic Acidosis (severe, PH <7.1) Ongoing Maintenance Of Normokalemia In Patients At Risk For Recurrent Hyperkalemia Phosphate Binder Potassium Binder Urinary Alkalinization (salicylate And Phenobarbital Toxicity)
Electrolytes 22 terms
Amiodarone Antiarrhythmics Antipsychotics Azithromycin Cardiac Monitoring Corrected QT Interval Defibrillation Electrolyte Imbalance Fluoroquinolones Haloperidol Hypocalcemia Hypokalemia Hypomagnesemia Long QT Syndrome Methadone Ondansetron QT Interval Repolarization Sotalol Sudden Cardiac Death Torsades De Pointes Twelve-Lead ECG
Gerontology 83 terms
ACE Inhibitor Acute Delirium Albumin Anticholinergic Cognitive Burden Scale Anticholinergic Toxidrome Atypical Presentation Autonomy Override Beers Criteria Benign Prostatic Hyperplasia Benzodiazepines Braden Scale CAM CAM-ICU CAUTI Chemical Restraint Clinical Frailty Scale Confusion Assessment Method Deconditioning Deep Tissue Pressure Injury Dehydration Delirium Dementia Dementia Attribution Error DIAPPERS Diphenhydramine Drug-Drug Interaction Eschar Fall Risk Falls Frailty Fried Frailty Phenotype Functional Decline Functional Incontinence Gait Belt Geriatric Syndrome GFR Hepatic Encephalopathy Homeostenosis Hospital-Associated Deconditioning Hypertensive Emergency I WATCH DEATH Ibuprofen Interprofessional Care Kegel Exercises Lactic Acidosis Malnutrition Metformin Mixed Incontinence Moisture Barrier Multifactorial Risk National Pressure Injury Advisory Panel NCLEX NGN NPIAP NSAIDs Opioids Orthostatic Hypotension Osteomyelitis Overactive Bladder Overflow Incontinence Pelvic Floor Physical Therapy Polypharmacy Post-operative Delirium Post-operative Safety Prescribing Cascade Pressure Injury Pressure Injury Staging Prompted Voiding Repositioning Sarcopenia Sepsis Slough STOPP/START Criteria Stress Incontinence Sundowning Tamsulosin Transient Incontinence Unstageable Pressure Injury Urge Incontinence Urinary Incontinence Urosepsis Warfarin Wernicke's Encephalopathy
GI agent 91 terms
5-HT3 Receptor Antagonist (GI-selective) Acute Diarrhea (non-infectious) Acute Non-specific Diarrhea Aminosalicylate (5-ASA Dimer Prodrug) Aminosalicylate (5-ASA Prodrug) Anorectal Conditions (hemorrhoids, Anal Fissure) Anti-inflammatory (IBD) Antidiarrheal Antidiarrheal / Opioid Agonist Bile Acid Bowel Prep Before Colonoscopy (high-dose GoLYTELY) Bowel Preparation Bowel Preparation Before Procedures Bulk-forming Laxative / Fiber Supplement Cervical Ripening And Labor Induction Chloride Channel Activator Chronic Diarrhea (adjunct) Chronic Diarrhea (IBD, Ileostomy) Chronic Idiopathic Constipation Chronic Idiopathic Constipation (adults) Chronic Idiopathic Constipation (CIC) Constipation Constipation (chronic And Occasional) Constipation (chronic) Constipation (short-term) Constipation Prevention (softening Hard Stools) Crohn Disease (colonic — Maintenance) Cytoprotective Agent Duodenal Ulcer Duodenal Ulcer Treatment And Prevention Erosive Esophagitis Erosive Esophagitis (healing And Maintenance) Esophagitis Gallstone Dissolution (small Cholesterol Stones) GERD GI Protective Agent / Antidiarrheal Guanylate Cyclase-C Agonist H. Pylori H. Pylori Eradication (combination Therapy) H. Pylori Eradication (component Of Triple Therapy) H. Pylori Eradication (quadruple Therapy) H2 Receptor Antagonist Heartburn Heartburn OTC Hepatic Encephalopathy (prevention And Treatment) Hypercholesterolemia (adjunct) Hypersecretory Conditions (Zollinger-Ellison Syndrome) ICU Stress Ulcer Prophylaxis (IV) Indigestion Irritable Bowel Syndrome (diarrhea-predominant) Irritable Bowel Syndrome With Constipation (IBS-C) Irritable Bowel Syndrome With Constipation (IBS-C) In Women ≥18 Years Laxative (osmotic) Laxative (osmotic) / Hyperammonemia Treatment Maintenance Of Remission In Ulcerative Colitis In Patients Intolerant To Sulfasalazine Medication Abortion (with Mifepristone) Mild To Moderately Active Ulcerative Colitis Missed Or Incomplete Miscarriage Management NAFLD/NASH (uncertain Benefit) Nausea Non-erosive GERD NSAID Gastroprotection NSAID-induced Ulcer NSAID-induced Ulcer Prophylaxis Opioid-induced Constipation (combined With Docusate) Opioid-induced Constipation (combined With Senna) Opioid-induced Constipation (non-cancer Patients) Peptic Ulcer Disease (duodenal And Gastric) Portal Systemic Encephalopathy Postoperative Constipation Postpartum Hemorrhage Potassium-competitive Acid Blocker (P-CAB) Prevention Of Hemorrhoid Recurrence Prevention Of NSAID-induced Gastric Ulcers Primary Biliary Cholangitis (PBC) Primary Sclerosing Cholangitis (limited Benefit) Prophylaxis During Rapid Weight Loss Or Bariatric Surgery Prostaglandin E1 Analog Proton Pump Inhibitor PUD Selective Serotonin Type-4 (5-HT4) Receptor Agonist Severe Diarrhea-predominant IBS (IBS-D) In Women Who Have Not Responded To Conventional Therapy Stimulant Laxative Stool Softener / Emollient Laxative Stress Ulcer Prophylaxis (ICU) Traveler's Diarrhea Traveler's Diarrhea (prophylaxis And Treatment) Ulcerative Colitis (mild-moderate) Zollinger-Ellison Zollinger-Ellison (high Doses) Zollinger-Ellison Syndrome
GU agent 16 terms
Anticholinergic / Antimuscarinic Benign Prostatic Hyperplasia (BPH) — Symptomatic Lower Urinary Tract Symptoms Beta-3 Adrenergic Agonist CPR (no Longer Recommended For Asystole Per 2010 ACLS) Erectile Dysfunction (Viagra) Neurogenic Detrusor Overactivity Ophthalmic Mydriasis Organophosphate/nerve Agent Poisoning (large Doses) Overactive Bladder (urge Incontinence, Urgency, Urinary Frequency) PDE-5 Inhibitor Pre-anesthetic (antisialagogue) Pulmonary Arterial Hypertension (Revatio) Raynaud's Phenomenon (off-label) Selective Alpha-1A/1D Adrenergic Antagonist Symptomatic Bradycardia (ACLS) Ureteral Calculi (facilitates Passage — Off-label)
hematopoietic agent 10 terms
Anemia Due To Chemotherapy In Non-myeloid Malignancies Anemia In HIV Patients On AZT Anemia Of Chronic Kidney Disease (dialysis And Non-dialysis Dependent) Chemotherapy-induced Neutropenia (primary And Secondary Prophylaxis) Erythropoiesis-stimulating Agent (ESA) Granulocyte Colony-stimulating Factor (G-CSF) Mobilization Of Peripheral Blood Progenitor Cells For Hematopoietic Stem Cell Transplantation Post-autologous/allogeneic HSCT Recovery Pre-surgical Autologous Blood Donation Severe Chronic Neutropenia (congenital, Cyclic, Idiopathic)
hormone 33 terms
Abnormal Uterine Bleeding Androgen Atrophic Vaginitis (low-dose Vaginal Formulations) Central Diabetes Insipidus Contraception (Depo-Provera IM Injection) Contraception (progestin-only Pill) Delayed Puberty In Males Emergency Contraception (Plan B: Within 72–120 Hours) Endometrial Cancer Palliative Treatment Endometrial Protection With Estrogen Replacement Endometriosis Endometriosis (Aygestin — Norethindrone Acetate) Endometriosis (Mirena) Estrogen Female Hypogonadism Female-to-male Transition Heavy Menstrual Bleeding (Mirena) Hormone Replacement In Transgender Men Hormone Replacement In Transgender Women Long-term Contraception (Mirena IUD Up To 7–8 Years) Long-term Contraception (Nexplanon Implant Up To 3 Years) Male Hypogonadism (primary Or Secondary) Menopausal Symptom Relief (hot Flashes, Genitourinary Syndrome Of Menopause) Mild Hemophilia A Nocturnal Enuresis Posterior Pituitary Hormone Analog Prevention Of Postmenopausal Osteoporosis Primary Ovarian Insufficiency Progestogen Secondary Amenorrhea Short-term Hormonal Contraception (NuvaRing Monthly) Uremic Bleeding Von Willebrand Disease Type 1 (hemostasis)
Hypertension 30 terms
Ace Inhibitors Aldosterone Alpha-Blockers Amlodipine Angiotensin II ARBs Atenolol Beta-Blockers Calcium Channel Blockers Cardiac Output Carvedilol Clonidine Diastolic Blood Pressure Furosemide Heart Failure Hydralazine Hydrochlorothiazide Hypertension Hypertensive Crisis Hypotension Lisinopril Losartan MAP Nifedipine Orthostatic Hypotension Peripheral Vascular Resistance Renin-Angiotensin-Aldosterone System Systolic Blood Pressure Thiazide Diuretics Valsartan
insulin 17 terms
Continuous Subcutaneous Insulin Infusion (insulin Pump) Critical Illness Hyperglycemia Diabetic Ketoacidosis (IV Infusion) Gestational Diabetes Hyperkalemia (with Dextrose) Insulin Insulin Pump Therapy (CSII) Total Parenteral Nutrition (insulin Supplementation) Type 1 Diabetes (bolus/mealtime Insulin) Type 1 Diabetes Mellitus Type 1 Diabetes Mellitus (basal Insulin) Type 1 Diabetes Mellitus (mealtime Coverage) Type 2 Diabetes (mealtime Insulin) Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus (basal Insulin) Type 2 Diabetes Mellitus (mealtime Coverage) Type 2 Diabetes Mellitus (mealtime Insulin)
leukotriene modifier 10 terms
5-lipoxygenase Inhibitor Allergic Rhinitis Aspirin-exacerbated Respiratory Disease Asthma (mild Persistent — Adjunct To ICS) Eosinophilic Esophagitis (off-label) Exercise-induced Bronchospasm Leukotriene Receptor Antagonist (LTRA) Persistent Asthma (maintenance Therapy, Adults And Adolescents 12 Years And Older) Persistent Asthma (maintenance Therapy, Adults And Children 5 Years And Older) Prophylaxis Of Exercise-induced Bronchospasm
local anesthetic antitussive 6 terms
mucolytic/expectorant 13 terms
Acetaminophen Overdose (IV/oral) — PRIORITY USE Antitussive Chest Congestion Associated With Upper Respiratory Infections, Bronchitis, Influenza Contrast Nephropathy Prevention (limited Evidence) COPD Exacerbation (inhaled) Cystic Fibrosis (daily Management To Improve Pulmonary Function And Reduce Respiratory Infections) Expectorant Loosening And Thinning Respiratory Secretions Mucolytic / Antidote Mucolytic Enzyme Mucolytic In Cystic Fibrosis/bronchiectasis Non-productive (dry) Cough Suppression Associated With Upper Respiratory Infections Productive Cough (expectorant)
Nephrology 22 terms
Autosomal Dominant Polycystic Kidney Disease Autosomal Recessive Polycystic Kidney Disease cAMP Signaling Chronic Kidney Disease End-Stage Renal Disease Genetic Counseling Hematuria Hepatic Cysts Hypertension Intracranial Aneurysm Kidney Transplantation Mitral Valve Prolapse mTOR Pathway Nephrolithiasis PKD1 PKD2 PKHD1 Renal Cysts Renal Tubular Epithelium Subarachnoid Hemorrhage Tolvaptan Urinary Tract Infection
neuromuscular blocking agent 8 terms
Facilitation Of Endotracheal Intubation Facilitation Of Endotracheal Intubation Where Rapid Onset And Short Duration Are Needed Facilitation Of Mechanical Ventilation In ICU Facilitation Of Mechanical Ventilation In ICU (preferred In Organ Failure) Intraoperative Skeletal Muscle Relaxation Neuromuscular Blocking Agent (NMBA) Rapid Sequence Intubation (RSI) RSI When Succinylcholine Is Contraindicated (with Sugammadex Available)
NSAID 22 terms
Actinic Keratosis (topical) Acute Gout Acute Gout (highly Effective) Acute Pain Ankylosing Spondylitis Bartter Syndrome Dysmenorrhea Familial Adenomatous Polyposis (FAP) Fever Inflammation Juvenile Idiopathic Arthritis (JIA) Moderate To Severe Pain (short-term, Up To 5 Days Only) Nonsteroidal Anti-inflammatory Drug (NSAID) Osteoarthritis Osteoarthritis (oral And Topical) Pain Pain (mild To Moderate) Patent Ductus Arteriosus Closure In Premature Neonates (IV) Pericarditis Post-operative Pain Renal Colic Rheumatoid Arthritis
Nursing Skills 23 terms
Active Listening Affirmations Ambivalence Behavior Change Change Talk Collaborative Communication Contemplation Stage Decisional Balance Empathy Evocation Motivational Interviewing OARS Open-Ended Questions Precontemplation Reflective Listening Resistance Rolling With Resistance Self-Efficacy Stages Of Change Summaries Sustain Talk Therapeutic Alliance Transtheoretical Model
opioid 32 terms
Acute Pulmonary Edema (IV) Analgesia In Mechanically Ventilated ICU Patients (short-term) Anesthesia Induction/maintenance Antitussive (cough Suppression) Chronic Cancer Pain Chronic Cancer Pain (transdermal Patch) Dyspnea In Palliative Care ICU Analgesia/sedation Induction And Maintenance Of General Anesthesia Mild To Moderate Pain Moderate To Moderately Severe Pain Moderate To Severe Acute Pain Moderate To Severe Pain Moderate-to-severe Acute Pain Moderate-to-severe Chronic Pain (Belbuca Buccal Film, Butrans Patch) Neonatal Opioid Withdrawal Syndrome (off-label) Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (ER Formulation) Off-label: Fibromyalgia Off-label: Restless Leg Syndrome Opioid Analgesic Opioid Analgesic (atypical) / Centrally Acting Analgesic Opioid Analgesic (atypical) / SNRI-like Analgesic Opioid Analgesic / Opioid Use Disorder Treatment Opioid Analgesic And Antitussive Opioid Dependence Induction Opioid Partial Agonist / Analgesic Opioid Use Disorder (maintenance Treatment) Opioid Use Disorder (OUD) — Maintenance And Detoxification Post-operative Pain Procedural Sedation/analgesia Procedural/breakthrough Pain Severe Chronic Pain (when Other Options Inadequate)
opioid antagonist 7 terms
Pathophysiology 22 terms
Autosomal Dominant Polycystic Kidney Disease Autosomal Recessive Polycystic Kidney Disease cAMP Signaling Chronic Kidney Disease End-Stage Renal Disease Genetic Counseling Hematuria Hepatic Cysts Hypertension Intracranial Aneurysm Kidney Transplantation Mitral Valve Prolapse mTOR Pathway Nephrolithiasis PKD1 PKD2 PKHD1 Renal Cysts Renal Tubular Epithelium Subarachnoid Hemorrhage Tolvaptan Urinary Tract Infection
Patient Safety 52 terms
Ace Inhibitors Aldosterone Alpha-Blockers Amiodarone Amlodipine Angiotensin II Antiarrhythmics Antipsychotics ARBs Atenolol Azithromycin Beta-Blockers Calcium Channel Blockers Cardiac Monitoring Cardiac Output Carvedilol Clonidine Corrected QT Interval Defibrillation Diastolic Blood Pressure Electrolyte Imbalance Fluoroquinolones Furosemide Haloperidol Heart Failure Hydralazine Hydrochlorothiazide Hypertension Hypertensive Crisis Hypocalcemia Hypokalemia Hypomagnesemia Hypotension Lisinopril Long QT Syndrome Losartan MAP Methadone Nifedipine Ondansetron Orthostatic Hypotension Peripheral Vascular Resistance QT Interval Renin-Angiotensin-Aldosterone System Repolarization Sotalol Sudden Cardiac Death Systolic Blood Pressure Thiazide Diuretics Torsades De Pointes Twelve-Lead ECG Valsartan
Pharmacology 201 terms
Ace Inhibitors Acetylcholine Acetylcholinesterase Acetylcholinesterase Inhibitor ACLS Activated Charcoal Adrenal Medulla Adrenergic Receptors Aging (Organophosphate) Aldosterone Alpha-1 Adrenergic Antagonists Alpha-1 Adrenergic Receptor Alpha-1 Receptors Alpha-2 Receptors Alpha-Blockers Amiodarone Amitriptyline Amlodipine Anaphylaxis Angiotensin II ANS Antiarrhythmics Anticholinergic Burden Anticholinergic Cognitive Burden Scale Anticholinergic Toxidrome Antipsychotics ARBs Atenolol Atrial Fibrillation Atropine Autonomic Nervous System Autosomal Dominant Polycystic Kidney Disease Autosomal Recessive Polycystic Kidney Disease Azithromycin Baroreceptor Reflex Beers Criteria Benign Prostatic Hyperplasia Benzodiazepines Beta Blocker Beta-1 Adrenergic Receptor Beta-1 Receptors Beta-2 Receptors Beta-3 Agonist Beta-3 Receptors Beta-Blockers Biphasic Anaphylactic Reaction Blood-Brain Barrier Calcium Channel Blockers cAMP Signaling Cardiac Monitoring Cardiac Output Cardiogenic Shock Cardioselective Beta Blockers Carvedilol Catechol-O-Methyltransferase Cholinergic Crisis Cholinergic Toxidrome Chromaffin Cells Chronic Kidney Disease CJMM Clonidine Cocaine Complete Heart Block Confusion Assessment Method COPD Corrected QT Interval Craniosacral Division Cycloplegia Cyp2D6 Defibrillation Delirium Depolarizing Block Deprescribing Desipramine Diastolic Blood Pressure Direct Muscarinic Agonists Doxepin Edrophonium Test Electrolyte Imbalance End-Stage Renal Disease Epinephrine Fluoroquinolones Fluoxetine Furosemide Genetic Counseling Glycogenolysis Glycopyrrolate Haloperidol Heart Failure Heart Failure with Reduced Ejection Fraction Hematuria Hepatic Cysts Hydralazine Hydrochlorothiazide Hypertension Hypertensive Crisis Hypocalcemia Hypokalemia Hypomagnesemia Hypotension Imipramine Indirect Cholinergic Agonists Infra-Nodal Conduction Block Intracranial Aneurysm Intralipid Juxtaglomerular Cells Kidney Transplantation Lipid Emulsion Therapy Lisinopril Long QT Syndrome Long-Acting Muscarinic Antagonist Losartan MAP Methadone Migraine Prophylaxis Mirabegron Mitral Valve Prolapse Mobitz Type II Monoamine Oxidase mTOR Pathway Muscarinic Antagonists Muscarinic Receptors Myasthenic Crisis Mydriasis Narrow Therapeutic Index NCSBN Clinical Judgment Measurement Model Negative Chronotropy Negative Inotropy Nephrolithiasis Nerve Agents Neuromuscular Junction Neuropathic Pain Nicotinic Effects Nicotinic Receptors Nifedipine Nocturnal Enuresis Non-Selective Beta Blockers Norepinephrine Nortriptyline Ondansetron Organophosphate Orthostatic Hypotension Overactive Bladder Oxygen Supply-Demand Mismatch Parasympathetic Nervous System Peripheral Vascular Resistance Phentolamine Pheochromocytoma Physostigmine PKD1 PKD2 PKHD1 Post-Operative Ileus Postherpetic Neuralgia Pralidoxime QRS Duration QT Interval QTc Prolongation Quaternary Ammonium Quaternary Ammonium Compound Rebound Sympathetic Activation Receptor Selectivity Renal Cysts Renal Tubular Epithelium Renin-Angiotensin-Aldosterone System Repolarization Rhabdomyolysis Selective Serotonin Reuptake Inhibitors Septic Shock Serotonin-Norepinephrine Reuptake Inhibitors Sinoatrial Node SLUD SLUDGE Sodium Bicarbonate Sodium Channel Blockade Sotalol Subarachnoid Hemorrhage Succinylcholine Sudden Cardiac Death Surviving Sepsis Campaign Sympathetic Nervous System Sympathomimetic Toxidrome Systolic Blood Pressure Tertiary Amine Thiazide Diuretics Thoracolumbar Division Tolvaptan Torsades De Pointes Toxidrome Transcutaneous Pacing Tricyclic Antidepressant Twelve-Lead ECG Two-Neuron Efferent Chain Unopposed Alpha Stimulation Urinary Retention Urinary Tract Infection Vagus Nerve Valsartan Vasopressor Ventricular Dysrhythmia Ventricular Remodeling
Preceptorship 37 terms
Adverse Drug Reaction AVPU Barcode Medication Administration Brain Sheet Clinical Assessment Code Status Documentation Double-Check Fall Prevention Fall Risk Glasgow Coma Scale Head-To-Toe Assessment Hendrich II Heparin High-Alert Medications Incident Report Independent Double-Check Informed Refusal Insulin IV Site Assessment MAR Medication Error Near Miss Patient Identification Patient Safety Phlebitis Polypharmacy Potassium Chloride PQRSTU Prioritization PRN Order SBAR Scheduled Medication Shift Handoff STAT Order Time Management Triage
Professional Development 37 terms
Adverse Drug Reaction AVPU Barcode Medication Administration Brain Sheet Clinical Assessment Code Status Documentation Double-Check Fall Prevention Fall Risk Glasgow Coma Scale Head-To-Toe Assessment Hendrich II Heparin High-Alert Medications Incident Report Independent Double-Check Informed Refusal Insulin IV Site Assessment MAR Medication Error Near Miss Patient Identification Patient Safety Phlebitis Polypharmacy Potassium Chloride PQRSTU Prioritization PRN Order SBAR Scheduled Medication Shift Handoff STAT Order Time Management Triage
Quality and Safety 20 terms
Bumetanide Cardiac Dysrhythmia Clinical Judgment Measurement Model Content Knowledge Smokescreen Diuretic-Induced Hypokalemia Electrolyte Depletion Furosemide Hemolysis Flag Hemolyzed Specimen Hyperkalemia Hypokalemia Iatrogenic Harm Loop Diuretics Next Generation NCLEX Pre-Analytical Error Premature Ventricular Contractions Protocol Shortcut Pseudohyperkalemia SBAR U Waves
Renal 49 terms
Ace Inhibitors Acetaminophen Acute Kidney Injury Acute-on-Chronic Kidney Injury Almost-Right Answer Aminoglycoside Ototoxicity Aminoglycosides ARBs AV Fistula Calcitriol Calcium Carbonate Chronic Kidney Disease Cinacalcet CJMM Compassion Trap Completeness Illusion Content Knowledge Smokescreen Contrast-Induced Nephropathy Dialysis Furosemide Gentamicin Hemodialysis Hypercalcemia Hyperkalemia Hyperkalemia-Induced Cardiac Conduction Change Hyperphosphatemia Interdialytic Weight Gain Kussmaul Respirations Metabolic Acidosis Metformin Nephrotoxicity NGN NSAIDs Parathyroid Hormone Peaked T-Waves Phosphate Binder Potassium Chloride Potassium Restriction Protein Moderation Protocol Shortcut Renal Diet Renal Osteodystrophy Renal Prostaglandin Synthesis Salt Substitute SBAR Serum Albumin Teach-Back Uremic Syndrome Ventricular Fibrillation
reversal agent 14 terms
Anticoagulant Reversal Agent Emergency Reversal Of Profound Rocuronium Blockade Heparin Rebound After CPB Neonatal Prophylaxis For Hemorrhagic Disease Neuromuscular Blockade Reversal Agent Partial Reversal Of LMWH (60-80%) Reversal Of Dabigatran Anticoagulation For Life-threatening Bleeding Or Emergency Surgery Reversal Of Rivaroxaban Or Apixaban For Life-threatening Bleeding Reversal Of Rocuronium-induced Neuromuscular Blockade (any Depth) Reversal Of UFH Reversal Of Vecuronium-induced Blockade Vitamin K / Warfarin Reversal Agent Vitamin K Deficiency Bleeding Warfarin Reversal (supratherapeutic INR)
sedative/hypnotic 11 terms
Approved For Long-term Use (unlike Zolpidem IR) Insomnia (sleep Onset And Maintenance) Insomnia (sleep Onset And Sleep Maintenance) Insomnia (sleep Onset; CR Formulation For Maintenance) Insomnia Characterized By Difficulty With Sleep Onset Jet Lag / Circadian Rhythm Disruption Melatonin Receptor Agonist Non-benzodiazepine Hypnotic (Z-drug) Orexin Receptor Antagonist Sedative-hypnotic Short-term Treatment Of Insomnia (sleep Onset Only; Not Sleep Maintenance)
targeted synthetic DMARD 2 terms
uric acid agent 9 terms
Adjunct To Penicillin Therapy (to Prolong Penicillin Levels By Blocking Renal Secretion) Chronic Gout In Patients With Hyperuricemia (when Allopurinol Has Failed Or Is Not Tolerated) Gout (chronic — To Increase Urate Excretion) Gout (prevention Of Attacks — Urate-lowering Therapy) Hyperuricemia (secondary Causes) Tumor Lysis Syndrome (prophylaxis) Uric Acid Nephrolithiasis Uricosuric Agent Xanthine Oxidase Inhibitor
vasodilator 2 terms
vasopressor 18 terms
Anaphylaxis (IM — First Line) Cardiac Arrest (ACLS — 1 Mg IV Q3-5 Min) Cardiac Arrest (no Longer In ACLS 2010) Cardiogenic Shock (adjunct) Croup (nebulized) Diabetes Insipidus (central) Distributive Shock Esophageal Varices Bleeding (IV) Hemodynamic Instability (shock — Cardiogenic, Distributive) Local Anesthesia Adjunct (vasoconstriction) Septic Shock (first-line Vasopressor) Septic Shock (vasodilatory — Adjunct To NE) Severe Bronchospasm/asthma (severe) Symptomatic Bradycardia (alternative To Pacing) Vasodilatory Shock (post-cardiac Surgery) Vasopressor Vasopressor / Bronchodilator Vasopressor/inotrope